BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21940481)

  • 1. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.
    Cavalier E; Delanaye P; Vranken L; Bekaert AC; Carlisi A; Chapelle JP; Souberbielle JC
    Nephrol Dial Transplant; 2012 May; 27(5):1950-6. PubMed ID: 21940481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of four different PTH methods on the classification of chronic kidney disease patients according to the new KDIGO guideline.
    Ten BE; Van Veen MC; Vervloet MG; Fischer JC; Koopman MG; Van Dam B
    Clin Lab; 2012; 58(7-8):719-24. PubMed ID: 22997972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
    Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M; Jean G; Bacri JL; Lemaitre V; Masy E; Joly D; Souberbielle JC
    Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
    Souberbielle JC; Cavalier E; Jean G
    Clin Chem Lab Med; 2010 Jun; 48(6):769-74. PubMed ID: 20298134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of vitamin D deficiency and consequences for PTH reference values.
    Deckers MM; de Jongh RT; Lips PT; Penninx BW; Milaneschi Y; Smit JH; van Schoor NM; Blankenstein MA; Heijboer AC
    Clin Chim Acta; 2013 Nov; 426():41-5. PubMed ID: 24012652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
    Kakuta T; Kato H; Komaba H; Akizawa T;
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
    Akiba T
    Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E; Salsé M; Dupuy AM; Bargnoux AS; Watar F; Souberbielle JC; Delanaye P; Cristol JP
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
    Shaheen FA; Kurpad R; Al-Sayyari AA; Souqiyyeh MZ; Aljubori H; El Baz T; Kashif W; Tuganbekova S; Kabulbayev K; Jarraya F; Nafar M
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R; Tentori F; Tighiouart H; Zager PG; Miskulin DC
    Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance with mineral metabolism targets in haemodialysis patients: moving backwards?
    Palomares I; Ramos R; Martin-Malo A; Merello JI; Praga M; Luño J; de Francisco AL;
    Blood Purif; 2013; 36(2):122-31. PubMed ID: 24217176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects.
    Souberbielle JC; Lawson-Body E; Hammadi B; Sarfati E; Kahan A; Cormier C
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3501-4. PubMed ID: 12915625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PTH measurement: where do we stand?].
    Marangella M
    G Ital Nefrol; 2009; 26(5):600-7. PubMed ID: 19802805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.